|

Carboplatin or Cisplatin Clinical Trials

4 actively recruiting trials across 2 locations

▼ -1 trial since June 2026

Also known as: chemotherapeutic drug

Pipeline

Phase 2: 4

Top Sponsors

  • University of Illinois at Chicago1
  • Shanghai Junshi Bioscience Co., Ltd.1
  • Second Hospital of Shanxi Medical University1
  • Hirva Mamdani1

Indications

  • Lung Cancer4
  • Cancer4
  • Extensive Stage-small Cell Lung Cancer2
  • Metastatic Squamous Non-Small Cell Lung Carcinoma1
  • Non-Squamous Non-Small Cell Lung Cancer1

Other2 trials

Phase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in Patients With Driver Gene-Positive, Advanced Non-Small Cell Lung Cancer After Failure of TKI Therapy
Phase 2
Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
Phase 2

Chicago, Illinois1 trial

A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC)

Ryan Nguyen

Phase 2

Indianapolis, Indiana1 trial

MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.